Geron: A Post Earnings And Funding Announcement Assessment

Group 1 - The biotech forum has seen significant discussions around profitable buy-write or covered call strategies on selected biotech stocks over the past few months [1] - Geron Corporation (NASDAQ: GERN) has experienced a busy and potentially transformative 18 months, marking a significant period for the company [2] - The investing group, The Biotech Forum, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat for trade ideas and weekly market commentary [2] Group 2 - The analyst has a beneficial long position in Geron Corporation shares through stock ownership, options, or other derivatives [3]